Terms: = Brain cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M
2459 results:
1. Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas.
Liu J; Hu S; Jiang H; Cui Y
Front Immunol; 2024; 15():1369972. PubMed ID: 38690285
[TBL] [Abstract] [Full Text] [Related]
2. Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With
Bruno F; Pellerino A; Conti Nibali M; Pronello E; Cofano F; Rossi M; Levis M; Bertero L; Soffietti R; Cassoni P; Garbossa D; Bello L; Rudà R
Neurology; 2024 May; 102(10):e209352. PubMed ID: 38684041
[TBL] [Abstract] [Full Text] [Related]
3.
Ou Y; Luo H; Zhang Q; Du T; Liu R; Wang D; Chen J; Dong M; Wang Y; Yang Z; Wang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):144. PubMed ID: 38682183
[TBL] [Abstract] [Full Text] [Related]
4. [Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors].
Wang SN; Wang W; Zhang XW; Zhang YQ; Xiong YL; Liu L; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):439-445. PubMed ID: 38678323
[No Abstract] [Full Text] [Related]
5. Supramaximal resection: retrospective study on idh-wildtype Glioblastomas based on the new RANO-Resect classification.
Tropeano MP; Raspagliesi L; Bono BC; Baram A; Rossini Z; Franzini A; Navarria P; Clerici E; Bellu L; Simonelli M; Scorsetti M; Riva M; Politi LS; Pessina F
Acta Neurochir (Wien); 2024 Apr; 166(1):196. PubMed ID: 38676720
[TBL] [Abstract] [Full Text] [Related]
6. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
7. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
[No Abstract] [Full Text] [Related]
8. Whole brain morphologic features improve the predictive accuracy of idh status and VEGF expression levels in gliomas.
Zhang S; Chen D; Sun H; Kemp GJ; Chen Y; Tan Q; Yang Y; Gong Q; Yue Q
Cereb Cortex; 2024 Apr; 34(4):. PubMed ID: 38642107
[TBL] [Abstract] [Full Text] [Related]
9. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract] [Full Text] [Related]
10. GPR27 expression correlates with prognosis and tumor progression in gliomas.
Cai C; Hu L; Wu K; Liu Y
PeerJ; 2024; 12():e17024. PubMed ID: 38638156
[TBL] [Abstract] [Full Text] [Related]
11. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
[TBL] [Abstract] [Full Text] [Related]
12. A 78-year-old woman with diffuse white matter infiltration and predominant involvement of bilateral temporo-parieto-occipital regions.
Paoli C; Mc Leer A; Boyer J; Mondot L; Dadone-Montaudié B; Godfraind C; Burel-Vandenbos F
J Cell Mol Med; 2024 Apr; 28(8):e18245. PubMed ID: 38613356
[TBL] [Abstract] [Full Text] [Related]
13. EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization.
Wilcock DM; Goold E; Zuromski LM; Davidson C; Mao Q; Sirohi D
J Neuropathol Exp Neurol; 2024 Apr; 83(5):338-344. PubMed ID: 38605523
[TBL] [Abstract] [Full Text] [Related]
14. Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases.
Kibe Y; Ohka F; Aoki K; Yamaguchi J; Motomura K; Ito E; Takeuchi K; Nagata Y; Ito S; Mizutani N; Shiba Y; Maeda S; Nishikawa T; Shimizu H; Saito R
Acta Neuropathol Commun; 2024 Apr; 12(1):57. PubMed ID: 38605367
[TBL] [Abstract] [Full Text] [Related]
15. Oligodendroglioma, idh-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.
Sasaki H; Kitamura Y; Toda M; Hirose Y; Yoshida K
Brain Tumor Pathol; 2024 Apr; 41(2):43-49. PubMed ID: 38564040
[TBL] [Abstract] [Full Text] [Related]
16. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
17. Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas.
Tuysuz EC; Mourati E; Rosberg R; Moskal A; Gialeli C; Johansson E; Governa V; Belting M; Pietras A; Blom AM
J Exp Clin Cancer Res; 2024 Apr; 43(1):98. PubMed ID: 38561856
[TBL] [Abstract] [Full Text] [Related]
18. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
[No Abstract] [Full Text] [Related]
19. Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
Jambor I; Steiner A; Pesola M; Gardberg M; Frantzén J; Jokinen P; Liimatainen T; Minn H; Aronen H; Merisaari H
PLoS One; 2024; 19(4):e0296958. PubMed ID: 38558074
[TBL] [Abstract] [Full Text] [Related]
20. The association between calreticulin and glucagon-like peptide-1 expressions with prognostic factors in high-grade gliomas.
Baran O; Akgun MY; Kayhan A; Evran S; Ozbek A; Akyoldas G; Samanci MY; Demirel N; Sonmez D; Serin H; Kocak A; Kemerdere R; Tanriverdi T
J Cancer Res Ther; 2024 Jan; 20(1):25-32. PubMed ID: 38554294
[TBL] [Abstract] [Full Text] [Related]
[Next]
